OLPX · Olaplex Holdings, Inc. · Stock research

Current Thesis

The story ended on schedule. Henkel completed its all-cash acquisition of Olaplex before the open on 2026-07-07, and each outstanding share was converted into the right to receive $2.06 in cash and cancelled. The shares were delisted from the Nasdaq Global Select Market the same day, with deregistration steps initiated. The last print was $2.07 on 2026-07-06, a hair through the deal price as arbs closed out. There is no listed OLPX security, no price series, and therefore no setup the ticker belongs in the historical file rather than any scan.

The full arc, for the record: announced 2026-03-26 at $2.06 (~55% premium to the 2026-03-25 close near $1.33, ~45% over the 30-day VWAP), shareholder-locked by Advent's written consent on 2026-05-04, cleared by the Bundeskartellamt on 2026-06-16, cleared by Australia's ACCC around 2026-06-20, with the US and UK gates satisfied in the final days of June. No second request, no extension toward the 2027 outside date, no break.

Bullish and bearish views on Olaplex Holdings, Inc.

The model's bull view on Olaplex Holdings, Inc. (OLPX), in brief: The deal paid in full: $2.06 per share in cash delivered at the 2026-07-07 close, against an announced value of ~$1.4B in equity. The bear view: The security no longer exists: delisted and deregistered as of 2026-07-07. Both cases follow in full.

Bull Case

• The deal paid in full: $2.06 per share in cash delivered at the 2026-07-07 close, against an announced value of ~$1.4B in equity. Holders of record received the full consideration with no downward adjustment.
• Regulatory path ran clean: German clearance came 2026-06-16 on a filing made 2026-05-15 one month for the buyer's home-market review, the gate most likely to produce friction. Australia followed within a week; the US and UK cleared without a published second request.
• Operations gave Henkel no MAC hook: Q1 2026, reported 2026-05-11, printed net sales of $99.4M, +2.5% YoY, gross margin 72.1%, Professional +12.3% and DTC +13.8% the first positive group comp after a multi-year decline. Balance sheet at 2026-03-31 was $326.2M cash against $352.5M long-term debt, near-zero net.
• There is no bull case left to underwrite. The above is settled history; none of it is forward-looking.

Bear Case

• The security no longer exists: delisted and deregistered as of 2026-07-07. Any quote, chart, or technical level a data vendor still surfaces for OLPX is a stale artifact.
• Zero forward optionality: the equity was cancelled at a fixed cash price. No trend, no squeeze, no re-rating.
• What the takeout actually rescued: the business had not fixed its problem. Specialty Retail fell 13.3% and US sales -3.5% in Q1 2026; the +2.5% group number leaned entirely on Professional and DTC. Shelf loss to K18, Redken, and L'Oréal-adjacent prestige was never reversed Henkel bought a distribution asset, not an inflection.
• The IPO-to-exit arithmetic is the cautionary line: public in September 2021 near $21, taken out at $2.06 in under five years.

Setup & Price Structure

There is no chart. The last tape was a flat peg at $2.05–$2.07 into the 2026-07-07 conversion, which is what a cash-locked equity does in its final weeks arbs collapse the spread and volume dries into the record date. Moving averages, RSI, breakout retests and volume expansion are all inapplicable to a security trading against a fixed cash ceiling, and doubly so to one that no longer trades at all.

For anyone modelling the terminal spread: at $2.05 against $2.06 with a July close, the gross was roughly 0.5% over a three-month regulatory tail. That is a fixed-income return with equity-style headline risk, and it was never the kind of asymmetry a momentum book exists to capture.

Catalyst Calendar (next 30 days)

• No future earnings, guidance, regulatory, or corporate-action dates are scheduled for this ticker, now or later.

Elapsed catalysts

• None. All dated events are behind: merger close 2026-07-07, delisting 2026-07-07, deregistration filings following. _(passed 12d ago)_
• 2026-06-16 Bundeskartellamt clearance (elapsed). _(passed 33d ago)_
• ~2026-06-20 ACCC clearance (elapsed). _(passed 29d ago)_
• 2026-05-11 final earnings report; guidance withdrawn and the conference call cancelled into the pending transaction. No further reporting obligation exists. _(passed 69d ago)_

What Would Change Our Mind

Nothing available in the market. The only theoretical path back to a listed Olaplex equity is Henkel re-floating or spinning the brand, which appears on no announced calendar and would take years. Absent that, the name is permanently retired from the watchlist.

The one live read that survives is negative and applies elsewhere: the Olaplex outcome is not a template for the rest of the distressed prestige-beauty complex. A $2.06 cash exit at ~90% below the 2021 IPO price is a rescue, not a valuation floor for peers.

Correlation Notes

• M&A special situations: while pending, OLPX correlated to nothing but its own deal spread beta to the tape was effectively zero from 2026-03-26 through delisting. That is the defining property of the cash-pegged bucket and the reason it does not belong in a trend book.
• Beauty peers (COTY, EL, ULTA, ELF): correlation broke on the 2026-03-26 announcement and never re-established. Post-close there is no residual read-across; Olaplex's takeout removed a share-donor from the category rather than repricing it.
• Henkel (HEN3.DE): the acquirer now carries the asset. Any forward interest in the Olaplex brand's trajectory routes through a German-listed consumer-goods name with a very different volatility profile.
• Stale-data risk: legacy theme tags on this ticker earlier registry passes attached "specialty-healthcare-late-cycle" and "semi-foundry-equipment" were misclassifications that persisted across regens. Worth flagging as a general reminder that theme drift on a dormant ticker compounds unnoticed.